These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia. Hirabayashi N, Goto S, Ishii M, Yuge M, Mitsuma A, Noda N. Bone Marrow Transplant; 1998 Jun; 21(11):1079-83. PubMed ID: 9645568 [Abstract] [Full Text] [Related]
9. Marrow transplantation for acute nonlymphoblastic leukemia in first remission. Thomas ED, Buckner CD, Clift RA, Fefer A, Johnson FL, Neiman PE, Sale GE, Sanders JE, Singer JW, Shulman H, Storb R, Weiden PL. N Engl J Med; 1979 Sep 13; 301(11):597-9. PubMed ID: 381925 [No Abstract] [Full Text] [Related]
10. Transplantation of T lymphocyte depleted bone marrow to prevent graft-versus-host disease: its implications for fetal liver transplantation. Champlin RE, Mitsuyasu RT, Gale RP. Prog Clin Biol Res; 1985 Sep 13; 193():315-25. PubMed ID: 3911215 [No Abstract] [Full Text] [Related]
11. Allogeneic bone marrow transplant in acute leukemias and chronic myeloid leukemia. Preliminary results from the BMT center of Pesaro. Izzi T, Polchi P, Galimberti M, Delfini C, Moretti L, Manna A, Porcellini A, Lucarelli G, Di Pietrantonj F. Haematologica; 1984 Sep 13; 69(2):194-210. PubMed ID: 6429005 [No Abstract] [Full Text] [Related]
13. Acute disseminated encephalomyelitis (ADEM) after allogeneic bone marrow transplantation for acute myeloid leukemia. Tomonari A, Tojo A, Adachi D, Iseki T, Ooi J, Shirafuji N, Tani K, Asano S. Ann Hematol; 2003 Jan 13; 82(1):37-40. PubMed ID: 12574963 [Abstract] [Full Text] [Related]
15. Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: an EBMT survey. European Blood and Marrow Transplantation Group. Arnold R, de Witte T, van Biezen A, Hermans J, Jacobsen N, Runde V, Gratwohl A, Apperley JF. Bone Marrow Transplant; 1998 Jun 13; 21(12):1213-6. PubMed ID: 9674854 [Abstract] [Full Text] [Related]
17. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP). Michel G, Leverger G, Leblanc T, Nelken B, Baruchel A, Landman-Parker J, Thuret I, Bergeron C, Bordigoni P, Esperou-Bourdeau H, Perel Y, Vannier JP, Schaison G. Bone Marrow Transplant; 1996 Feb 13; 17(2):191-6. PubMed ID: 8640165 [Abstract] [Full Text] [Related]
18. Unexplained effusions: association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease. Pretnar J, Cernelc P, Mlakar U, Fortuna M. Bone Marrow Transplant; 1996 Oct 13; 18(4):826. PubMed ID: 8899209 [No Abstract] [Full Text] [Related]
20. Experience with bone marrow transplantation for severe aplastic anemia and leukemia. Two years experience with 31 patients in Zagreb (Yugoslavia). Labar B, Bogdanic V, Kastelan A, Vrtar M, Grgic-Markulin L, Balabanic-Kamauf B, Francetic I, Dobric I, Grgicevic D, Kerhin-Brkljacic V. Biomed Pharmacother; 1986 Oct 13; 40(9):332-7. PubMed ID: 3548836 [Abstract] [Full Text] [Related] Page: [Next] [New Search]